22157.jpg
Insights on the Radiotherapy Market to 2028 - by Type, Product, Application, End-user and Geography
August 24, 2021 06:53 ET | Research and Markets
Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Product, Application, and End User, and Geography" report has been...
Curium Announces Sub
Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T
August 24, 2021 02:15 ET | Curium
ST. LOUIS, MO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Curium announced today that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Cu-64...
22157.jpg
Global $12.17 Billion Nuclear Medicine Markets to 2028: Beta-emitters, PET, SPECT, Alpha-emitters, Brachytherapy
June 29, 2021 04:13 ET | Research and Markets
Dublin, June 29, 2021 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, By Type; By Modality; By Application; By End-Use; By Regions; Segment Forecast,...
mono.jpg
Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery
May 24, 2021 08:00 ET | Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional...
22157.jpg
Global Radiopharmaceuticals Market Report 2021: High Cost of Radiopharmaceuticals is Anticipated to Limit the Growth of the Market
May 24, 2021 05:08 ET | Research and Markets
Dublin, May 24, 2021 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Curium Announces Fil
Curium Announces Filing of a Generic Version of DaTscanᵀᴹ (Ioflupane I 123 Injection) in the U.S.
May 04, 2021 02:30 ET | Curium
St. Louis, MO, May 04, 2021 (GLOBE NEWSWIRE) -- Curium announced today that it submitted an abbreviated new drug application for a generic version of DaTscan (Ioflupane I 123 Injection) with the...
Curium to Expand Nob
Curium to Expand Noblesville Facility’s Workforce
April 28, 2021 02:30 ET | Curium
St. Louis, MO, April 28, 2021 (GLOBE NEWSWIRE) -- Curium, the world’s largest nuclear medicine company, has announced plans to invest in new jobs at its Noblesville location – furthering its...
22157.jpg
Global Radiopharmaceutical Market (2020 to 2025) - by Type, Application, Procedure, End-user and Geography
March 15, 2021 06:28 ET | Research and Markets
Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "Global Radiopharmaceutical Market (2020-2025) by Type, Application, Procedure, End-User, Geography, Competitive Analysis and the Impact of Covid-19...
RadioMedix & Curium
RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate injection)
January 26, 2021 02:30 ET | Curium
St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a...
LOGO.jpg
QSAM Biosciences Receives Favorable Safety Results in Study for its Leading Radiopharmaceutical Drug Candidate
January 21, 2021 09:00 ET | QSAM Biosciences Inc.
Palm Beach, FL, Jan. 21, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear medicines for the treatment of cancer and related diseases and...